s13da_011813-achillion.htm
 
 
 
CUSIP No. 000448Q201

  SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC  20549
 
SCHEDULE 13D
(Rule 13d-101)
 
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 2)1
 
Achillion Pharmaceuticals, Inc.
(Name of Issuer)
 
Common Stock, $.001 par value
 
(Title of Class of Securities)
 
00448Q201
(CUSIP Number)
 
 
Domain Associates, LLC
Ropes & Gray LLP
 
One Palmer Square
1211 Avenue of the Americas
 
Princeton, NJ  08542
New York, NY 10036
 
Attn: Kathleen K. Schoemaker
Attn: Morri Weinberg, Esq.
 
Tel: (609) 683-5656
Tel: (212) 596-9000
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
 
January 18, 2013
Date of Event Which Requires Filing of This Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following box.    o

Note.  Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits.  See Rule 13d-7 for other parties to whom copies are to be sent.



 
1 The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 
 
 
CUSIP No. 00448Q201


 
1.
  
NAME OF REPORTING PERSONS
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (voluntary)
  
Domain Partners VIII, L.P.
 
2.
 
 
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
 
(a)x
(b)o
 
3.
 
SEC USE ONLY
 
4.
  
SOURCE OF FUNDS
 Not Applicable
 
5.
  
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS
IS  REQUIRED PURSUANT TO ITEM 2(d) or 2(e)
 o
 
6.
  
CITIZENSHIP OR PLACE OF ORGANIZATION
  
Delaware
 
 
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
 
 
7.   
  SOLE VOTING POWER
8,563,507*
 
8.
  
SHARED VOTING POWER
0
 
9.
  
SOLE DISPOSITIVE POWER
8,563,507*
 
10.
  
SHARED DISPOSITIVE POWER
0
 
11.
  
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
8,563,507*
 
12.
 
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11)
EXCLUDES CERTAIN SHARES
 
13.
  
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
10.4%
 
14.
  
TYPE OF REPORTING PERSON
PN

*Includes 2,790,539 shares issuable upon exercise of Warrants.


 
-2-
 
CUSIP No. 00448Q201


 
1.
  
NAME OF REPORTING PERSONS
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (voluntary)
DP VIII Associates, L.P.
 
2.
 
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
 
(a)x
(b)o
 
3.
 
SEC USE ONLY
 
4.
  
SOURCE OF FUNDS
 
 Not Applicable
 
5.
  
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS  REQUIRED PURSUANT TO ITEM 2(d) or 2(e)
 o
 
6.
  
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
 
 
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
 
 
7.
  
SOLE VOTING POWER
79,867*
 
8.
  SHARED VOTING POWER
 0
 
9.
 
SOLE DISPOSITIVE POWER
79,867*
 
10.
  
SHARED DISPOSITIVE POWER
0
 
11.
  
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
79,867*
 
12.
 
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11)
EXCLUDES CERTAIN SHARES                                                                
 
13.
  
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0.1%
 
14.
  
TYPE OF REPORTING PERSON
PN

*Includes 20,706 shares issuable upon exercise of Warrants.


 
 
-3-
 
CUSIP No. 00448Q201


 
1.
  
NAME OF REPORTING PERSONS
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (voluntary)
Domain Associates, LLC
 
2.
 
 
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
 
(a)x
(b)o
 
3.
 
SEC USE ONLY
 
4.
  
SOURCE OF FUNDS
 
Not Applicable
 
5.
  
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS  REQUIRED PURSUANT TO ITEM 2(d) or 2(e)
o
 
6.
  
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
 
 
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
 
 
7.
  
SOLE VOTING POWER
 
25,000
 
8.
  
SHARED VOTING POWER
0
 
9.
  
SOLE DISPOSITIVE POWER
 
25,000
 
10.
  
SHARED DISPOSITIVE POWER
0
 
11.
  
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
25,000
 
12.
 
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11)
EXCLUDES CERTAIN SHARES                                                                
 
13.
  
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
Less than 0.1%
 
14.
  
TYPE OF REPORTING PERSON
OO

 

 
-4-
 
CUSIP No. 00448Q201


AMENDMENT NO. 2 TO SCHEDULE 13D

Reference is hereby made to the statement on Schedule 13D filed with the Securities and Exchange Commission (the “Commission”) by the Reporting Persons with respect to the Common Stock of the Issuer on August 30, 2010 and Amendment No. 1 thereto filed on June 15, 2012 (as so amended, the “Schedule 13D”).  Terms used in the Schedule 13D are used herein as so defined.

The following items of the Schedule 13D are hereby amended as follows:


Item 5.     Interest in Securities of the Issuer.

Item 5(a) is hereby amended and restated to read in its entirety as follows:
 
(a)     The information requested by this paragraph is incorporated herein by reference to the information provided on the cover pages to this Amendment No. 2 to Schedule 13D. This information is based on a total of 79,517,386  shares of Common Stock outstanding as of  November 1, 2012, as reported in the Issuer’s Report on Form 10-Q for the period ended September 30, 2012 filed with the Commission on November 8, 2012, and gives effect to the exercise of all Warrants held by the Reporting Persons.  In addition to the shares that  OPSA VIII indirectly beneficially owns in its capacity as the general partner of DP VIII and DP VIIIA, OPSA VIII directly beneficially owns 159,896 shares of Common Stock, or approximately 0.2% of the Common Stock outstanding.

Item 5(c) is hereby amended and restated to read in its entirety as follows:

(c)     On July 18, 2013, DP VIII distributed in kind 1,000,000 shares of Common Stock pro rata to its partners, including 66,462 shares to OPSA VIII.

 
 

 

 
-5-
 
CUSIP No. 00448Q201


SIGNATURES

After reasonable inquiry and to the best of their knowledge and belief, the undersigned certify that the information set forth in this statement is true, complete and correct.

Dated: January 18, 2013

 
DOMAIN PARTNERS VIII, L.P.
 
By:
One Palmer Square Associates VIII, LLC, General Partner
 
 
 
By:
/s/ Kathleen K. Schoemaker
   
Managing Member
 
 
DP VIII ASSOCIATES, L.P.
 
By:
One Palmer Square Associates VIII, LLC., General Partner
 
 
 
By:
/s/ Kathleen K. Schoemaker
   
Managing Member
 
 
DOMAIN ASSOCIATES, LLC
   
 
 
 
 
By:
/s/ Kathleen K. Schoemaker
   
Managing Member